Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment is a new chief internal medicine officer. | The newest executive to join ...

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

US pharma giant Pfizer (NYSE: PFE) today announced that James List, has joined the company as chief internal medicine officer ...

Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine portfolio and will be responsible for advancing the ...

Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to lead R&D in obesity drugs. Read more here.

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of heart disease and obesity medicines. The drugmaker said in ...

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio, Bayer’s gene therapy ...

Australians pay some of the lowest medicine prices in the world for a reason: our Pharmaceutical Benefits Scheme. Here’s how ...